HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by HALHALI, A. Articles by LARREA, F. Search for Related Content PubMed PubMed Citation Articles by HALHALI, A. Articles by LARREA, F.

Calcitonin Gene- and Parathyroid Hormone-Related Peptides in Preeclampsia: Effects of Magnesium Sulfate

From the Department of Reproductive Biology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, México D.F., México; and the Department of Internal Medicine, University of Texas Medical Branch, Galveston, Texas.

Address reprint requests to: Ali Halhali, PhD Department of Reproductive Biology Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán Vasco de Quiroga No 15 Col. Tlalpan CP 14000, México, DF México E-mail: alih{at}quetzal.innsz.mx

Objective: To determine whether circulating levels of calcitonin gene-related peptide (CGRP) and parathyroid hormone-related peptide (PTHrP) are altered in preeclampsia, and to assess the effects of magnesium sulfate therapy on circulating levels of these two peptides.

Methods: The study population included 25 women with preeclampsia and 25 normotensive controls of similar gestational age. The effects of magnesium sulfate therapy were evaluated in 17 of the 25 preeclamptic women. Circulating levels of immunoreactive CGRP and PTHrP, including calcium, magnesium, and phosphate in the maternal and umbilical cord serum were measured.

Results: The frequency of preeclampsia subjects with nondetectable PTHrP (under 3 pg/mL) was significantly higher (92% versus 48%, P < .001), whereas maternal serum CGRP levels were significantly lower (50 ± 19 versus 90 ± 23 pg/mL, P < .001). Similarly, the frequency of newborns with nondetectable PTHrP levels in umbilical serum was significantly higher (68% versus 36%, P < .05), whereas the levels of CGRP were significantly lower (67 ± 17 versus 79 ± 16 pg/mL, P < .05). Magnesium sulfate treatment resulted in a significant increase in maternal circulating CGRP levels (64 ± 17 versus 47 ± 18 pg/mL, P < .05) with no changes in PTHrP.

Conclusion: Maternal circulating PTHrP and CGRP concentrations were significantly lower in women with preeclampsia, which may contribute to the development and maintenance of hypertension during pregnancy. Furthermore, magnesium sulfate therapy increased the levels of CGRP in the maternal circulation.

This article has been cited by other articles:

				Y.-L. Dong, D. M. Reddy, K. E. Green, M. S. Chauhan, H.-Q. Wang, M. Nagamani, G. D.V. Hankins, and C. Yallampalli Calcitonin Gene-Related Peptide (CALCA) Is a Proangiogenic Growth Factor in the Human Placental Development Biol Reprod, May 1, 2007; 76(5): 892 - 899. [Abstract] [Full Text] [PDF]

				K.E. Green, C. Thota, G.D.V. Hankins, C. Yallampalli, and Y.-L. Dong Calcitonin gene-related peptide stimulates human villous trophoblast cell differentiation in vitro Mol. Hum. Reprod., July 1, 2006; 12(7): 443 - 450. [Abstract] [Full Text] [PDF]

				Y.-L. Dong, K. E. Green, S. Vegiragu, G. D. V. Hankins, E. Martin, M. Chauhan, C. Thota, and C. Yallampalli Evidence for Decreased Calcitonin Gene-Related Peptide (CGRP) Receptors and Compromised Responsiveness to CGRP of Fetoplacental Vessels in Preeclamptic Pregnancies J. Clin. Endocrinol. Metab., April 1, 2005; 90(4): 2336 - 2343. [Abstract] [Full Text] [PDF]

				E. Maioli, V. Fortino, and A. Pacini Parathyroid Hormone-Related Protein in Preeclampsia: A Linkage Between Maternal and Fetal Failures Biol Reprod, December 1, 2004; 71(6): 1779 - 1784. [Abstract] [Full Text] [PDF]